Hanall Biopharma Net Asset Momentum
Hanall Biopharma net asset momentum. Hanall Biopharma (009420) recorded a net asset momentum of -9.6% as of December 2024, with net assets of ₩168.35 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Hanall Biopharma's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Hanall Biopharma (2011–2024)
Net asset momentum of Hanall Biopharma from 2011 to 2024. This chart tracks Hanall Biopharma's year-over-year net asset growth across 14 annual reporting periods from 2011 to 2024. The most recent momentum reading is -9.6%, with net assets of ₩168.35 Billion KRW as of December 2024. Check 009420 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Hanall Biopharma Net Asset Momentum by Year (2011–2024)
Hanall Biopharma net asset momentum by year from 2011 to 2024. The table below shows the complete annual net asset history for Hanall Biopharma from 2011 to 2024, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 009420 market cap.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩168.35 Billion | ₩212.88 Billion | ₩44.53 Billion | ▼ -9.6% |
| 2023 | ₩186.22 Billion | ₩239.75 Billion | ₩53.53 Billion | ▲ +10.7% |
| 2022 | ₩168.26 Billion | ₩213.45 Billion | ₩45.19 Billion | ▲ +2.9% |
| 2021 | ₩163.49 Billion | ₩198.48 Billion | ₩34.99 Billion | ▼ -9.8% |
| 2020 | ₩181.27 Billion | ₩220.13 Billion | ₩38.86 Billion | ▲ +29.1% |
| 2019 | ₩140.42 Billion | ₩191.38 Billion | ₩50.97 Billion | ▲ +20.1% |
| 2018 | ₩116.92 Billion | ₩162.30 Billion | ₩45.39 Billion | ▲ +5.1% |
| 2017 | ₩111.20 Billion | ₩168.70 Billion | ₩57.50 Billion | ▲ +6.6% |
| 2016 | ₩104.36 Billion | ₩124.73 Billion | ₩20.37 Billion | ▲ +9.6% |
| 2015 | ₩95.22 Billion | ₩117.13 Billion | ₩21.91 Billion | ▲ +107.9% |
| 2014 | ₩45.81 Billion | ₩87.17 Billion | ₩41.36 Billion | ▼ -23.2% |
| 2013 | ₩59.63 Billion | ₩97.85 Billion | ₩38.23 Billion | ▼ -24.2% |
| 2012 | ₩78.67 Billion | ₩124.27 Billion | ₩45.60 Billion | ▲ +55.2% |
| 2011 | ₩50.70 Billion | ₩105.46 Billion | ₩54.75 Billion | — |